A citation-based method for searching scientific literature

Roel H P Wouters, Rhodé M Bijlsma, Geert W J Frederix, Margreet G E M Ausems, Johannes J M van Delden, Emile E Voest, Annelien L Bredenoord. Trends Mol Med 2018
Times Cited: 5







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Points to consider for laboratories reporting results from diagnostic genomic sequencing.
D F Vears, K Sénécal, A J Clarke, L Jackson, A M Laberge, L Lovrecic, A Piton, K L I Van Gassen, H G Yntema, B M Knoppers,[...]. Eur J Hum Genet 2018
31
40

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
842
40

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
40

Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.
Shoko Vos, Johannes J M van Delden, Paul J van Diest, Annelien L Bredenoord. Trends Genet 2017
12
40



Genomic diagnosis for children with intellectual disability and/or developmental delay.
Kevin M Bowling, Michelle L Thompson, Michelle D Amaral, Candice R Finnila, Susan M Hiatt, Krysta L Engel, J Nicholas Cochran, Kyle B Brothers, Kelly M East, David E Gray,[...]. Genome Med 2017
99
20

Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.
Frederick E Dewey, Michael F Murray, John D Overton, Lukas Habegger, Joseph B Leader, Samantha N Fetterolf, Colm O'Dushlaine, Cristopher V Van Hout, Jeffrey Staples, Claudia Gonzaga-Jauregui,[...]. Science 2016
281
20

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Laura M Amendola, Michael O Dorschner, Peggy D Robertson, Joseph S Salama, Ragan Hart, Brian H Shirts, Mitzi L Murray, Mari J Tokita, Carlos J Gallego, Daniel Seung Kim,[...]. Genome Res 2015
225
20

Identification of Medically Actionable Secondary Findings in the 1000 Genomes.
Emily Olfson, Catherine E Cottrell, Nicholas O Davidson, Christina A Gurnett, Jonathan W Heusel, Nathan O Stitziel, Li-Shiun Chen, Sarah Hartz, Rakesh Nagarajan, Nancy L Saccone,[...]. PLoS One 2015
52
20


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

Diagnostic exome sequencing in persons with severe intellectual disability.
Joep de Ligt, Marjolein H Willemsen, Bregje W M van Bon, Tjitske Kleefstra, Helger G Yntema, Thessa Kroes, Anneke T Vulto-van Silfhout, David A Koolen, Petra de Vries, Christian Gilissen,[...]. N Engl J Med 2012
987
20

Actionable secondary findings from whole-genome sequencing of 954 East Asians.
Clara Sze-Man Tang, Saloni Dattani, Man-Ting So, Stacey S Cherny, Paul K H Tam, Pak C Sham, Maria-Mercè Garcia-Barcelo. Hum Genet 2018
23
20

The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience.
Lauren Lawrence, Murat Sincan, Thomas Markello, David R Adams, Fred Gill, Rena Godfrey, Gretchen Golas, Catherine Groden, Dennis Landis, Michele Nehrebecky,[...]. Genet Med 2014
42
20

Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.
Pradeep Natarajan, Nina B Gold, Alexander G Bick, Heather McLaughlin, Peter Kraft, Heidi L Rehm, Gina M Peloso, James G Wilson, Adolfo Correa, Jonathan G Seidman,[...]. Sci Transl Med 2016
38
20

Diagnostic exome sequencing in 266 Dutch patients with visual impairment.
Lonneke Haer-Wigman, Wendy Ag van Zelst-Stams, Rolph Pfundt, L Ingeborgh van den Born, Caroline Cw Klaver, Joke Bgm Verheij, Carel B Hoyng, Martijn H Breuning, Camiel Jf Boon, Anneke J Kievit,[...]. Eur J Hum Genet 2017
59
20

HGVS Recommendations for the Description of Sequence Variants: 2016 Update.
Johan T den Dunnen, Raymond Dalgleish, Donna R Maglott, Reece K Hart, Marc S Greenblatt, Jean McGowan-Jordan, Anne-Francoise Roux, Timothy Smith, Stylianos E Antonarakis, Peter E M Taschner. Hum Mutat 2016
668
20

Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.
Mi-Ae Jang, Sang-Heon Lee, Namshin Kim, Chang-Seok Ki. Genet Med 2015
28
20

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Tara M Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Kwong, Edith Olah, Olufunmilayo I Olopade, Angela R Solano, Soo-Hwang Teo,[...]. Hum Mutat 2018
119
20

Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory.
Samuel P Strom, Hane Lee, Kingshuk Das, Eric Vilain, Stanley F Nelson, Wayne W Grody, Joshua L Deignan. Genet Med 2014
88
20

Genomic sequencing identifies secondary findings in a cohort of parent study participants.
Michelle L Thompson, Candice R Finnila, Kevin M Bowling, Kyle B Brothers, Matthew B Neu, Michelle D Amaral, Susan M Hiatt, Kelly M East, David E Gray, James M J Lawlor,[...]. Genet Med 2018
13
20

Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?
Saumya Shekhar Jamuar, Jyn Ling Kuan, Maggie Brett, Zenia Tiang, Wilson Lek Wen Tan, Jiin Ying Lim, Wendy Kein Meng Liew, Asif Javed, Woei Kang Liew, Hai Yang Law,[...]. EBioMedicine 2016
14
20

Robustness of DNA repair through collective rate control.
Paul Verbruggen, Tim Heinemann, Erik Manders, Gesa von Bornstaedt, Roel van Driel, Thomas Höfer. PLoS Comput Biol 2014
10
20

Computational approaches to mapping allosteric pathways.
Victoria A Feher, Jacob D Durrant, Adam T Van Wart, Rommie E Amaro. Curr Opin Struct Biol 2014
84
20

The origin of allosteric functional modulation: multiple pre-existing pathways.
Antonio del Sol, Chung-Jung Tsai, Buyong Ma, Ruth Nussinov. Structure 2009
270
20


Functional impact bias reveals cancer drivers.
Abel Gonzalez-Perez, Nuria Lopez-Bigas. Nucleic Acids Res 2012
199
20

Folding and binding cascades: shifts in energy landscapes.
C J Tsai, B Ma, R Nussinov. Proc Natl Acad Sci U S A 1999
268
20


Cancer missense mutations alter binding properties of proteins and their interaction networks.
Hafumi Nishi, Manoj Tyagi, Shaolei Teng, Benjamin A Shoemaker, Kosuke Hashimoto, Emil Alexov, Stefan Wuchty, Anna R Panchenko. PLoS One 2013
61
20

CryptoSite: Expanding the Druggable Proteome by Characterization and Prediction of Cryptic Binding Sites.
Peter Cimermancic, Patrick Weinkam, T Justin Rettenmaier, Leon Bichmann, Daniel A Keedy, Rahel A Woldeyes, Dina Schneidman-Duhovny, Omar N Demerdash, Julie C Mitchell, James A Wells,[...]. J Mol Biol 2016
81
20


Computational approaches for the identification of cancer genes and pathways.
Christos M Dimitrakopoulos, Niko Beerenwinkel. Wiley Interdiscip Rev Syst Biol Med 2017
26
20

Allosteric inhibition through suppression of transient conformational states.
Shiou-Ru Tzeng, Charalampos G Kalodimos. Nat Chem Biol 2013
74
20

Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.
James V Michael, Lawrence E Goldfinger. Semin Cancer Biol 2019
9
20

Colorectal cancer microenvironment: among nutrition, gut microbiota, inflammation and epigenetics.
Paolo Garagnani, Chiara Pirazzini, Claudio Franceschi. Curr Pharm Des 2013
26
20

Synthetic lethality between gene defects affecting a single non-essential molecular pathway with reversible steps.
Andrei Zinovyev, Inna Kuperstein, Emmanuel Barillot, Wolf-Dietrich Heyer. PLoS Comput Biol 2013
16
20

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Siân Jones, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, Hirohiko Kamiyama, Antonio Jimeno,[...]. Science 2008
20

Regulation of K-Ras4B Membrane Binding by Calmodulin.
Benjamin Sperlich, Shobhna Kapoor, Herbert Waldmann, Roland Winter, Katrin Weise. Biophys J 2016
32
20

Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer.
Francesco Abate, Sakellarios Zairis, Elisa Ficarra, Andrea Acquaviva, Chris H Wiggins, Veronique Frattini, Anna Lasorella, Antonio Iavarone, Giorgio Inghirami, Raul Rabadan. BMC Syst Biol 2014
41
20

Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology.
Stefanie Broes, Denis Lacombe, Michiel Verlinden, Isabelle Huys. Front Med (Lausanne) 2018
8
20

Unraveling structural mechanisms of allosteric drug action.
Ruth Nussinov, Chung-Jung Tsai. Trends Pharmacol Sci 2014
84
20

KRAS: feeding pancreatic cancer proliferation.
Kirsten L Bryant, Joseph D Mancias, Alec C Kimmelman, Channing J Der. Trends Biochem Sci 2014
377
20

ROS-mediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubule-targeting agents.
Marion Le Grand, Amandine Rovini, Veronique Bourgarel-Rey, Stephane Honore, Sonia Bastonero, Diane Braguer, Manon Carre. Oncotarget 2014
28
20

Pharmacogenomics in the age of personalized medicine.
Leslie J Dickmann, Joseph A Ware. Drug Discov Today Technol 2016
19
20

Recent computational advances in the identification of allosteric sites in proteins.
Shaoyong Lu, Wenkang Huang, Jian Zhang. Drug Discov Today 2014
66
20

Unsupervised detection of cancer driver mutations with parsimony-guided learning.
Runjun D Kumar, S Joshua Swamidass, Ron Bose. Nat Genet 2016
29
20

Independent and core pathways in oncogenic KRAS signaling.
Ruth Nussinov, Chung-Jung Tsai, Hyunbum Jang. Expert Rev Proteomics 2016
13
20

Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.
Min Ju Park, Hailian Shen, Jason M Spaeth, Jaana H Tolvanen, Courtney Failor, Jennifer F Knudtson, Jessica McLaughlin, Sunil K Halder, Qiwei Yang, Serdar E Bulun,[...]. J Biol Chem 2018
21
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.